Coronavirus Update: Inside Moderna's Deal With The US

Plus: Generex Forges Vaccine Partnership

19 Aug 2020

• By Scrip Team

Company receives a base payment of $1.225bn for the manufacturing and delivery of the first 100 million disease, plus a bonus if mRNA-1273 reaches the market quickly.

A cyclist wearing a mask in New York's Times Square.

An 8-K filing with the US Securities and Exchange Commission has pulled back the blinds on the deal Moderna, Inc. reached to supply the US with its COVID-19 vaccine mRNA-1273. On 11 August, the company announced it had signed a deal with the US Department of Defense to provide an initial 100 million doses of the vaccine for $1.525bn.

That includes a base payment of $1.225bn for the manufacturing and delivery of the first 100 million disease, plus a...